Drug Week
Susan Hasty, Publisher
Table of Contents . . . September 6th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
Erectile Dysfunction - Viagra helps men with heart failure
HIV/AIDS Therapy - Once-daily HIV Medications pave way for simplified combination drug regimens
Asthma - Millennium discontinues oral MLN977 program
Chronic Pain - Pivotal phase III program for the Chronogesic (sufentanil) initiated
Irritable Bowel Syndrome - FDA approves Zelnorm for IBS with constipation
AIDS Therapy - T-20 administration has little impact on daily activities of patients after 8 weeks of treatment
Adrenocortical Steroids - FDA gives nod to generic prednisolone oral solution
Adverse Drug Effects - Drug eruption study yields surprising results
Breast Cancer - Drugs typically used in later stages find a market in early stages as well
Canker Sores - Access Pharmaceuticals commences final phase III OraDisc A study
Cardiac Therapy - Enrollment for Tecadenoson trial complete; CVT-3146 advances to phase III
Contraception - Clinical trial of 7-day combination patch initiated
Endometriosis - Women's health company seeks to raise $15M; begins phase II trials
Generics - Watson Receives FDA approval for Nizatidine
HIV/AIDS Therapy - Panacos unveils the leading compound in a new class of HIV drug candidates: budding inhibitors
HIV/AIDS Therapy - Serono announces significant results from two clinical trials of Serostim
HIV/AIDS Vertical Transmission - Short-course nevirapine doesn't improve standard preventive therapy
Hepatitis B - FDA advisers plug new drug
Infectious Disease Therapy - Effective anti-Ebola agent may work by augmenting interferon output
Legal Issues - Michigan Attorney General Granholm continues battle against illegal drug pricing actions
Mental Health - Oklahoma HMO seeks ruling on antipshychotic drug
Nephropathy - FDA grants fast track status for Pyridorin
Patents - NexMed receives new patent for Alprox-TD
Rheumatoid Arthritis - Study evaluates impact of treatment with Remicade plus methotrexate
Sialorrhea - Quigley announces phase II clinical study on QR-334 formulation
Technology - Data capture firm releases product for phase IV clinical trials
Thyroid Disease - Endocrinologists applaud FDA confirmation of safety, efficacy of Synthroid
Tuberculosis Therapy - Gender, AIDS status do not affect isoniazid levels
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
